Member Info for ChrisToffer

To answer that Trek1234 you would have to think about what this could be worth (no easy thing to do btw). The current market cap is 300m but the COPD readout that is due next month could double that valuation alone.

Thats without considering the pandemic and the benefit this could prove to be in helping to end it. Like 79% chance of helping.

That's dated the 8th of April Foxy. Suffice to say there have been one or two developments since then.

“Imagine if we had done this work five years earlier, this drug could have been stockpiled by governments,” Marsden said. “And, when coronavirus emerged in Wuhan we could have given this to all healthcare workers and anyone exposed on cruise ships or elsewhere.”

The results on Monday have naturally prompted the discussion over treating hospitalised patients as a reactive response to CV19 but that above quote suggests to me that RM is already promoting its uses as a proactive measure for exposed people/areas. The potential there is huge!

CONSPIRACY!

Hi Algy, I'm Irish, live in Cambridge but also work in the Middle East! Go figure haha if this comes off like we hope then I'm up for SynairGin wherever! :D

I thought it almost made them out to be mercenaries and definitely paraphrased RM on the "its only reasonable" quote.

It is only reasonable that these guys have spent 15 years of their lives developing a broad spectrum antiviral that just happens to not only combat this pandemic but potentially many more, and that they won't roll over to pharma companies and let that go cheap.

Anyone who was invested in an African low cost airline whilst all the conglomerates were falling apart around them needs to step back and assess their strategy.

Yea anyone could have been right with late July prediction. Its just a guess at the end of the day. I think you also made a wayward prediction on the COPD results Nolupus, so you're hardly mystic meg! Having said that I've appreciated your views, and everyone else's, throughout!

MF, your arguments are considered in the context of due process and how these things normally would go. However with a problem this size where thousands are dying every day and governments are pouring 100's of millions (in the eu case, 750 billion) into the economy to fix it. Don't you think that'll have an effect l?

MF, I'm not buying over £2 as I have an average of 44p. I haven't top sliced anything because the current value is 2-300m pending the peer review that you allude to. If you research any of the people involved in the development of this drug you will understand that a peer review will be a very straight forward process. There is a lot less risk now than a week ago, its only a matter of time.

MF, the company have just released results showing an 79% chance of improvement on hospitalised covid patients.

Put a price on that!

A timely reminder Goose! When I think about the line of questioning in the webinar and the other comments from members of the scientific community this week (the naysayers), I went back over pre results videos of Prof.Holgate on this treatment, he has always maintained 'we don't know this yet!'

This is from a week ago, pre results https://youtu.be/puNpFv6u_Wc (about 45 mins in they talk about interferon treatment.)

Fast forward to Mondays webinar and he's not saying that any more!

The SP hasn't sat at 200m for any length of time throughout this week ya header. A 200m market cap is a SP of 135p

MIKODX. Google SNG share price. Look at the MCAP. Divide by the shares in issue (149m) and tell us if it equals the share price.

If anyone has any doubts over the integrity of Synairgens claims on Monday or whether they will be agreed with on peer review, have a YouTube search of Professor Holgate talking about this treatment. He doesn't mince his words and is not prone to making empty claims.

MIKODX, thats not correct lad. The current MCAP is the shares currently in issue X the SP. The shares in issue will not change unless the company issue more through fundraise.

Thats a different type of Interferon. Interferon A. SNG001 is Interferon Beta which is supposedly better at combating coronaviruses.

Good analysis Joey,

I would add that Inf B has been shown to be more effective against coronavirus than Inf A.

Thats the beauty of a licencing agreement isn't it?

For example; If SNG were to licence to Gilead. The first thing Gilead will do is point to remdesivir and say'well ya gave us approval for that'

The guys were grilled on this during Mondays webinar. They are obliged by market rules to report their findings which is why there are supposed holes to pick in the results.
Anyone who has been following this for a while will tell you that Richard Marsden, Professor Holgate and Tom Wilkinson are not prone to making grand claims or over stating things unless they have the facts to back them up.

Its only a matter of time before everyone else cathes up with what they know they have.